Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised

Tarih
2005
Yazar
Simon, C
Gerken, G
Hansen, B
Zondervan, P
Niesters, HGM
de Man, RA
So, TMJ
Schalm, SW
Janssen, HLA
van Zonneveld, M
Senturk, H
Zeuzem, S
Akarca, US
Cakaloglu, Y
Üst veri
Tüm öğe kaydını göster
Özet
Background Treatment of HBeAg-positive patients with chronic hepatitis B is not effective in most. A combination of immunomodulatory pegylated interferon alfa-2b and antiviral lamivudine might improve the rate of sustained response.
Bağlantı
http://hdl.handle.net/20.500.12627/156883
https://doi.org/10.1016/s0140-6736(05)17701-0
Koleksiyonlar